Oleuropein inhibits pancreatic cancer through miR-190b-5p induction

Background: Pancreatic cancer has the highest mortality rate of all major cancers. Till now, surgical resection is considered the only potentially curative therapy. The aim of this study was to study oleuropein (Ole) as an alternative treatment for pancreatic cancer. Methods: First, we determine...

Full description

Bibliographic Details
Main Authors: Qian Xu, Xiaobing Huang, Ningzi Wu, Peifeng Hou
Format: Article
Language:English
Published: Innovation Publishing House Pte. Ltd. 2022-04-01
Series:STEMedicine
Subjects:
Online Access:https://stemedicine.org/index.php/stem/article/view/125
_version_ 1819018859090280448
author Qian Xu
Xiaobing Huang
Ningzi Wu
Peifeng Hou
author_facet Qian Xu
Xiaobing Huang
Ningzi Wu
Peifeng Hou
author_sort Qian Xu
collection DOAJ
description Background: Pancreatic cancer has the highest mortality rate of all major cancers. Till now, surgical resection is considered the only potentially curative therapy. The aim of this study was to study oleuropein (Ole) as an alternative treatment for pancreatic cancer. Methods: First, we determined the tumor-inhibitory effect of Ole in pancreatic cancer cell lines and the KPC mouse model. Second, we employed microarray and real-time polymerase chain reaction to identify microRNAs (miRNA) regulated by Ole in pancreatic cancer. Third, we mapped out the downstream target of the miRNA candidate by luciferase assay and western blotting. Finally, we measured the tissue expression of the miRNA candidate in clinical samples. Both in vitro and in vivo studies supported Ole treatment suppressed pancreatic cancer. Results: We profiled miRNAs changes induced by Ole and identified miR-190b-5p as a novel functional player in Ole-mediated pancreatic cancer suppression. Further on, we reported that TCF4 in Wnt signaling was a direct target of miR-190b-5p. The suppression of Wnt signaling by miR-190b-5p was attributed to Ole-induced tumor inhibition in a pancreatic cancer model. Finally, we showed that miR-190b-5p was downregulated in human clinical cancer samples. Conclusion: In summary, we discovered that Ole carried anti-pancreatic cancer function. MiR-190b-5p induced by Ole was a potential therapeutic target.
first_indexed 2024-12-21T03:26:06Z
format Article
id doaj.art-4fd415a0ea774110b6edd5f658ad3c89
institution Directory Open Access Journal
issn 2705-1188
language English
last_indexed 2024-12-21T03:26:06Z
publishDate 2022-04-01
publisher Innovation Publishing House Pte. Ltd.
record_format Article
series STEMedicine
spelling doaj.art-4fd415a0ea774110b6edd5f658ad3c892022-12-21T19:17:35ZengInnovation Publishing House Pte. Ltd.STEMedicine2705-11882022-04-013210.37175/stemedicine.v3i2.125Oleuropein inhibits pancreatic cancer through miR-190b-5p inductionQian Xu0Xiaobing Huang1Ningzi Wu2Peifeng Hou3Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaDepartment of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaFujian Medical University, Fuzhou, Fujian, ChinaDepartment of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China; and Stem Cell Research Institute, Fujian Medical University, Fuzhou, Fujian, China Background: Pancreatic cancer has the highest mortality rate of all major cancers. Till now, surgical resection is considered the only potentially curative therapy. The aim of this study was to study oleuropein (Ole) as an alternative treatment for pancreatic cancer. Methods: First, we determined the tumor-inhibitory effect of Ole in pancreatic cancer cell lines and the KPC mouse model. Second, we employed microarray and real-time polymerase chain reaction to identify microRNAs (miRNA) regulated by Ole in pancreatic cancer. Third, we mapped out the downstream target of the miRNA candidate by luciferase assay and western blotting. Finally, we measured the tissue expression of the miRNA candidate in clinical samples. Both in vitro and in vivo studies supported Ole treatment suppressed pancreatic cancer. Results: We profiled miRNAs changes induced by Ole and identified miR-190b-5p as a novel functional player in Ole-mediated pancreatic cancer suppression. Further on, we reported that TCF4 in Wnt signaling was a direct target of miR-190b-5p. The suppression of Wnt signaling by miR-190b-5p was attributed to Ole-induced tumor inhibition in a pancreatic cancer model. Finally, we showed that miR-190b-5p was downregulated in human clinical cancer samples. Conclusion: In summary, we discovered that Ole carried anti-pancreatic cancer function. MiR-190b-5p induced by Ole was a potential therapeutic target. https://stemedicine.org/index.php/stem/article/view/125oleuropeinmiR-190b-5pTCF4Wnt/β-cateninpancreatic cancer
spellingShingle Qian Xu
Xiaobing Huang
Ningzi Wu
Peifeng Hou
Oleuropein inhibits pancreatic cancer through miR-190b-5p induction
STEMedicine
oleuropein
miR-190b-5p
TCF4
Wnt/β-catenin
pancreatic cancer
title Oleuropein inhibits pancreatic cancer through miR-190b-5p induction
title_full Oleuropein inhibits pancreatic cancer through miR-190b-5p induction
title_fullStr Oleuropein inhibits pancreatic cancer through miR-190b-5p induction
title_full_unstemmed Oleuropein inhibits pancreatic cancer through miR-190b-5p induction
title_short Oleuropein inhibits pancreatic cancer through miR-190b-5p induction
title_sort oleuropein inhibits pancreatic cancer through mir 190b 5p induction
topic oleuropein
miR-190b-5p
TCF4
Wnt/β-catenin
pancreatic cancer
url https://stemedicine.org/index.php/stem/article/view/125
work_keys_str_mv AT qianxu oleuropeininhibitspancreaticcancerthroughmir190b5pinduction
AT xiaobinghuang oleuropeininhibitspancreaticcancerthroughmir190b5pinduction
AT ningziwu oleuropeininhibitspancreaticcancerthroughmir190b5pinduction
AT peifenghou oleuropeininhibitspancreaticcancerthroughmir190b5pinduction